Authors
Shuya Wang, Xiaojing Shi, Tingli Xiong, Wenxuan Zheng, Ruishi Li, Yuting Lin, Min Liu, Jiawen Wei, Fei Li, Qiong Huang, Kelong Ai
Published in
Science bulletin. Nov 09, 2026. Epub Nov 09, 2026.
Abstract
Neuronal apoptosis induced by mitochondrial dysfunction and neuronal ferroptosis induced by glutathione peroxidase 4 (GPX4) inactivation are the root causes of cerebral ischemia-reperfusion injury (CIRI). Inspired by the "catalytic tetrad" of the GPX4 catalytic center, this study ingeniously developed a self-driving neural guardian nanomedicine (SNG). SNG successfully retains the most critical selenol group for GPX4's catalytic function and a strategically positioned carboxyl group in close proximity, allowing SNG to exhibit excellent GPX-mimicking activity. Due to the genipin-like group, SNG can autonomously navigate to target ischemic brain areas, and further precisely anchor to neuronal mitochondria. Based on its potent GPX4 mimetic activity and released active Se, SNG can fundamentally reverse neuronal ferroptosis. Furthermore, SNG itself possesses antioxidant properties and can spontaneously degrade to release genipin. Therefore, it ameliorates neuronal mitochondrial dysfunction during CIRI through the dual effects of mitochondrial reactive oxygen species (mtROS) scavenging and inhibition of excessive activation of mitochondrial uncoupling protein 2 (UCP2). SNG suppresses the release of mitochondrial DNA (mtDNA), which subsequently inhibits inflammation. This work provides a breakthrough approach for the treatment of CIRI by synergistically inhibiting neuronal ferroptosis, neuronal apoptosis, and neuroinflammation, while also offering new directions for the treatment of other ischemia-reperfusion diseases.
PMID:
43064560
Bibliographic data and abstract were imported from PubMed on 21 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 2
- Comments 0